Evidera’s late-phase interventional study team, made up of dedicated peri- and post-approval experts, can design and execute efficient, fit-for-purpose studies that help you meet regulator requirements and achieve optimal commercialization. With deep knowledge of peri- and post-market requirements, our experienced team can navigate those requirements to position your product for future success.
Build a larger body of evidence around a product or specific patient population to better inform clinical practice
Enable optimal commercialization and market access for your product
Generate data to address peri- and post-approval evidence gaps
Meet regulator and payer requirements for post-marketing effectiveness and safety
Our team leverages the global power, therapeutic expertise, and deep clinical development experience of PPD to seamlessly transition earlier phase studies to late-phase studies. We utilize PPD’s network of physicians and product development experts to execute studies focused on operational excellence. With extensive experience across all interventional study types, we can execute cost-effective trials across the globe drawing on our experience in more than 70 countries, including China and Japan.
When designing and executing studies, we leverage Evidera’s multi-disciplinary team of scientists and evidence generation strategists to leverage relevant real-world data and high-quality patient-centered data. Our interventional team leverages our patient-centered research experts, the largest dedicated team of its kind in the field, to incorporate COAs, PROs, patient preferences, and the patient voice into studies.
Fill out the form below and one of our representatives will be in touch.
